CellSight Technologies
PrivateLast Round
SBIR Phase
II
Sep 16, 2022
Total Funding Raised
$2.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CellSight Technologies operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a SBIR Phase II round in September 2022.
CellSight Technologies is a biotechnology company that develops PET imaging tracers for diagnostic imaging in the immunotherapy field.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellSight Technologies Comparables
Compare CellSight Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoSite Bio | 88% | |
| imuveo | 83% | |
| Telix Pharmaceuticals | 81% |
For institutional investors. Book with your work email.
CellSight Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SBIR Phase II | Sep 16, 2022 | ||||
| Corporate Funding | Nov 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellSight Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | SBIR Phase II, SBIR Phase I |
| Boehringer Ingelheim | Corporate Funding |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 55% MoM, reaching 1.2K.
- Jul 28, 2026
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
CellSight Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellSight Technologies's valuation, stock price, and market status.
Is CellSight Technologies a public or private company?
CellSight Technologies is a private company.
What is the current stock price of CellSight Technologies?
CellSight Technologies is a private company, so its shares have no public market price. Caplight tracks CellSight Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellSight Technologies worth (valuation)?
Valuation information for CellSight Technologies is not publicly available.
Can I buy CellSight Technologies stock?
CellSight Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellSight Technologies's last funding round?
CellSight Technologies's most recent funding round was SBIR Phase II on September 16, 2022.
Who are the main investors in CellSight Technologies?
Key investors in CellSight Technologies include National Cancer Institute, Boehringer Ingelheim, NIH RADx.
Will CellSight Technologies IPO soon?
No public IPO plans have been announced for CellSight Technologies.
How can I track CellSight Technologies secondary market activity?
Caplight tracks bids, offers, and trades in CellSight Technologies's shares on secondary markets.